NTRK1 and neoplasm: For instance, although the morphologic spectrum of neurotrophic tyrosine receptor kinase (NTRK) fusion tumors was heterogenous, and included an undesignated tumor lineage, NTRK1-3 fusions in solid tumors were revealed as tumor-agnostic marker of response to treatment with a selective inhibitor (10).